Skip to main content
Clinical Trials/IRCT20200708048051N2
IRCT20200708048051N2
Recruiting
Phase 3

Clinical Trial of Evaluation of the effects of intranasal desmopressin on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery

Rasht University of Medical Sciences0 sites120 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Rasht University of Medical Sciences
Enrollment
120
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Rasht University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • all patients with chronic rhino\-sinusitis with or without nasal polyps candidate for functional endoscopic sinus surgery

Exclusion Criteria

  • patients with abnormal coagulation tests
  • patients with history of cardiovascular disease
  • patients with coagulopathy
  • anticoagulant drug users
  • patients with cerebrovascular disease
  • patients with sinonasal tumors
  • pregnant women
  • herbal or vitamin E drug users
  • sinus revision surgery
  • corticosteroid drug users

Outcomes

Primary Outcomes

Not specified

Similar Trials